Avogaro, P., Bon, G.B., Cozzolato, G. & Quinci, G.B. (1979). Are apolipoproteins better discriminators than lipids for atherosclerosis. Lancet. i: 901-903.
2.
Ball, M. & Mann, J. (1988). Lipids and heart disease; A practical approach . Oxford: Oxford Medical Publications .
3.
Basinski, A., Frank, J.W., Naylor, C.D. & Rachlis, M.M. (1989). Detection and management of asymptomatic hypercholesterolaemia. A policy document by the Toronto Working Group on Cholesterol Policy. Toronto: Ontario Ministry of Health.
4.
Brett, A.S. (1989). Treating hypercholesterolaemia. How should practising physicians interpret the published data for patients? N. Engl. J. Med., 321: 676-679.
5.
Committee On Medical Aspects Of Food Policy ( 1984). Diet and cardiovascular disease. London: HMSO.
6.
Feinleib, M. (1981). On a possible inverse relationship between serum cholesterol and cancer mortality. Am. J. Epidemiol., 114: 5-10.
7.
Forette, B., Tortrat, D. & Wolmark, Y. (1989). Cholesterol as risk factor for mortality in elderly women. Lancet, i: 868-870.
8.
Gaber, A.M. (1989). Where to draw the line against cholesterol. Ann. Int. Med., 111: 625-626.
9.
Gordon, T., Castelli, W.P., Hjortland, M.C., Kannel, W.B. & Dauber, T.R. (1977). High density lipoprotein as a protective factor against coronary heart disease. The Framingham StudyAm. J. Med., 62, 707-714.
10.
Helsinki Heart Study (1987). Primary prevention trial with gemfibrozil in middle aged men with dyslipidaemia . N. Engl. J. Med., 317,1237-1245. Isles, G.G., Hole, D.J., Gillis, C.R., Hawthorne, V.M. & Lever, A.F. (1989). Plasma cholesterol, coronary heart disease, and cancer in the Renfrew and Paisley Survey. Br. Med. J., 298: 920-924.
11.
Jacobs, D. & Barrett-Connor, E. (1982). Re-test reliability of plasma cholesterol and triglycerides. The Lipid Research Clinics Prevalence Study. Am. J. Epidemiol., 116: 878-885.
12.
Lee, H.A. & Dickerson, J.W.T. (1988). Diet and cardiovascular disease. In: Diet in the clinical management of disease, pp 191-210. Eds. Dickerson, J. W. T. and Lee, H. A.London: Arnold.
13.
Lewis, B., Hammett, F., Katan, M., Kay, R.M., Merkx, I., Nobels, A., Miller, N.E. & Swan, A.V. (1981). Towards an improved lipid-lowering diet: additive effects of changes in nutrient intake. Lancet, ii: 1310-1313.
14.
Lipid Research Clinics Program (1984). The lipid research clinics coronary primary prevention trials results . J.A.M.A., 251: 351-364.
Martin, M.J., Hulley, S.B., Browner, W.S., Kuller, L.H. & Wentworth, D. (1986). Serum cholesterol, blood pressure and mortality: implications from a cohort of 361,622 men. Lancet, ii: 933-936.
17.
Miller, G.J. & Miller, N.E. (1975). Plasma-high-density-lipoprotein concentration and development of ischaemic heart disease. Lancet, i: 16-19.
18.
Miller, N.E., Thelle, D.S., Forde, O.H. & Mjos, O.D. (1977). The Tromsø heart study. High density lipoprotein and coronary heart disease: a prospective case-control study. Lancet, i: 965-970.
19.
National Advisory Committee On Nutrition Education (1983). Proposals for nutritional guidelines for health education in Britain. London: Health Education Council.
20.
National Cholesterol Education Program (1988 ). Report of the National Cholesterol Education Program Expert Panel on detection, evaluation and treatment of blood cholesterol in adults . Arch. Intern. Med., 148: 36-69.
21.
Oliver, M.F. (1981). Serum cholesterol — the knave of hearts and the joker. Lancet, ii: 1090-1095.
22.
Shepherd, J., Betteridge, D.J., Durrington, P., Laker, M., Lewis, B., Mann, J., Miller, J.P., Reckless, J.P.D. & Thompson, G.R. (1987). Strategies for reducing coronary heart disease and desirable limits for blood lipid concentrations: guidelines of the British Hyperlipidaemia Association. Br. Med. J., 295: 1245-1246.
23.
Stamler, J., Wentworth, D. & Neaton, J.D. (1986). Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). J.A.M.A., 256: 2823-2828.
